5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole
C86H142N14O6 — CID 161166310
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole
5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole (PubChem CID 161166310) has the molecular formula C86H142N14O6 and a molecular weight of 1468.17 g/mol. Its IUPAC name is 5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole.
Molecular Properties
| Compound Name | 5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole |
|---|---|
| PubChem CID | 161166310 |
| Molecular Formula | C86H142N14O6 |
| Molecular Weight | 1468.17 g/mol |
| Exact Mass | 1467.12 |
| IUPAC Name | 5-tert-butyl-3-cyclopropyl-1,2,4-oxadiazole;1-tert-butyl-3,3-dimethylpyrrolidin-2-one;5-tert-butyl-1-methylpyrazole;2-tert-butyl-6-methylpyridine;3-tert-butyl-2-nitropyridine;(1R,4R)-5-tert-butyl-2-oxa-5-azabicyclo[2.2.1]heptane;1-(4-tert-butylpiperidin-1-yl)ethanone;2-tert-butylpyridine-3-carbonitrile;4-tert-butyl-1,3,5-trimethylpyrazole |
| SMILES | CC(=O)N1CCC(C(C)(C)C)CC1.CC(C)(C)N1C[C@H]2C[C@@H]1CO2.CC(C)(C)c1cccnc1[N+](=O)[O-].CC(C)(C)c1nc(C2CC2)no1.CC(C)(C)c1ncccc1C#N.CC1(C)CCN(C(C)(C)C)C1=O.Cc1cccc(C(C)(C)C)n1.Cc1nn(C)c(C)c1C(C)(C)C.Cn1nccc1C(C)(C)C |
| InChI | InChI=1S/C11H21NO.C10H18N2.C10H12N2.C10H19NO.C10H15N.C9H12N2O2.C9H14N2O.C9H17NO.C8H14N2/c1-9(13)12-7-5-10(6-8-12)11(2,3)4;1-7-9(10(3,4)5)8(2)12(6)11-7;1-10(2,3)9-8(7-11)5-4-6-12-9;1-9(2,3)11-7-6-10(4,5)8(11)12;1-8-6-5-7-9(11-8)10(2,3)4;1-9(2,3)7-5-4-6-10-8(7)11(12)13;1-9(2,3)8-10-7(11-12-8)6-4-5-6;1-9(2,3)10-5-8-4-7(10)6-11-8;1-8(2,3)7-5-6-9-10(7)4/h10H,5-8H2,1-4H3;1-6H3;4-6H,1-3H3;6-7H2,1-5H3;5-7H,1-4H3;4-6H,1-3H3;6H,4-5H2,1-3H3;7-8H,4-6H2,1-3H3;5-6H,1-4H3/t;;;;;;;7-,8-;/m.......1./s1 |
| InChIKey | UQOVZDOBVYDEDY-CZIKBMCESA-N |
| XLogP | 19.11 |
| TPSA | 233.25 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 106 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1468.17 |
| LogP ≤ 5 | 19.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161166310 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.